Merck & Co. Inc. (NYSE:MRK), the US pharmaceutical company, launched its first bond in euros for seven years on Monday, just days after its €1.5bn deal from 2007 had matured. With markets recovering after a queasy time last week, the €2.5bn issue was widely seen as a success by rival bankers. Merck & Co. Inc. (NYSE:MRK) in last trading activity fell -0.93% to close at $58.66. Company weekly performance is -2.07% while its quarterly performance stands at 1.56%. Merck & Co. Inc. (NYSE:MRK) is -3.80% away from its 52 week high.Google Inc. (NASDAQ:GOOGL) has informed the man who filed a lawsuit against the U.S. Internet giant that it is considering complying with a Japanese court order to remove some online search results found to infringe on the man’s privacy rights, his lawyer said Friday. On last trading day Google Inc (NASDAQ:GOOGL) fell -2.74% to close at $555.19. Its volatility for the week is 1.98% while volatility for the month is 1.52%. GOOGL's sales growth for past 5 years was 22.40% and its EPS growth for past 5 years was 22.10%. Google Inc (NASDAQ:GOOGL) monthly performance is -6.08%.A suggestion Thursday by Microsoft Corporation (NASDAQ:MSFT)’s chief executive officer suggesting that women in technology should not ask for raises but have faith in the “system” brought a torrent of criticism and caused the executive to backtrack after the statement. Microsoft Corporation (NASDAQ:MSFT) in last trading activity decreased -3.97% to close at $44.03. Company weekly performance is -4.47% while its quarterly performance stands at 5.13%. Microsoft Corporation (NASDAQ:MSFT) is -7.44% away from its 52 week high.Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company") on 26 September 2014 announced a number of changes to management and its board of directors that will become effective October 1, 2014. The Board of Directors has appointed Dr. Joseph M. Patti as the Company's President and Chief Executive Officer and as a director of the Company. Dr. Patti is replacing Russell H. Plumb, the Company's current President and Chief Executive Officer, who will assume the role of Executive Chairman of the Board of Directors and will continue to have certain other ongoing responsibilities with the Company. Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) has 0.60% insider ownership while its institutional ownership stands at 48.20%. In last trading activity company's stock closed at $2.41.Colorado-based company Emerald Oil Inc (NYSEMKT:EOX), to contrast, has been focusing on expanding its operations. The company recently received three permits for Bakken Formation wells in Richland County, Montana. The company also recently announced that it had acquired the Williston Basin properties in North Dakota, a 4,250 net acre acquisition that could boost the company’s production from wells in the area. On Friday shares of Emerald Oil, Inc. (NYSEMKT:EOX) closed at $4.33. Company's sales growth for last 5 years was 27.00% and EPS growth for next 5 years is recorded as 40.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
